Pharmafile Logo
Pharmafocus logo
Advanced Search

Business Services

Pharmaceutical Business Services – News, analysis and company profiles

Showing 15 posts of 2465 posts found.

China CDE clears Phase 3 Study of Lisafltoclax in Newlly Diagnosed Patients with Higher-Risk Myelodysplastic Syndrome

August 13, 2024 Clinical Research, Research and Development Ascentage Pharma, Oncology

The China Centre for Drug Evaluation (CDE) has cleared the registrational phase 3 study of lisaftoclax in combination with azacitadine …
News

Drug discovery and development partnership announced between Apollo Therapeutics and Oxford University

July 31, 2024 Clinical Research, Medical Communications, Research and Development Apollo Therapeutics, Internal Medicine, Microbiology, drug development, drug discovery, research

Portfolio therapeutics company Apollo Therapeutics has announced earlier this week that it will provide capital and expertise to Oxford University’s …
News

Eisai and EcoNaviSta enter dementia collaboration

July 25, 2024 Business Services EcoNaviSta, Eisai, Neurology, collaboration, dementia

Eisai and EcoNaviSta have announced that they have entered into a business alliance agreement, initiating their collaboration intended to build …
News

Agilent to acquire BIOVECTRA for $925m

July 24, 2024 Business Services Agilent, CMDO, Pharmacy, acquisition

Agilent Technologies has announced that it has signed a definitive agreement to acquire BIOVECTRA, a leading specialised contract development and …
News

ViroCell Biologics signs Master Services Agreement with NCI-designated cancer centre

July 23, 2024 Business Services Cancer, Oncology, ViroCell Biologics, agreement

ViroCell Biologics has announced that it has signed a five-year Master Services Agreement (MSA) with a prominent US-based NCI-designated cancer …
News

Loci Orthopaedics announces €12.8m series A financing

July 17, 2024 Business Services Financing, Musculo-skeletal disorder, investment, loci orthopaedics

Loci Orthopaedics has announced the successful closing of an oversubscribed €12.8m series A financing, which was led by new investors …
News

Renalys Pharma closes ¥6bn series A financing for kidney disease treatments in Asia

July 17, 2024 Business Services Financing, Nephrology, kidney disease, renalys Pharma

Renalys Pharma has announced that it has completed ¥6bn series A financing, which was led by Catalys Pacific and SR …
News

Aspect Biosystems announces partnership with governments of Canada and British Columbia

July 11, 2024 Business Services Aspect Biosciences, Pharmacy, government, investment

Aspect Biosystems has announced that it has entered into an agreement with the governments of Canada and British Columbia, under …
News

Pharmaxo acquired by Icon Group in strategic partnership

July 10, 2024 Business Services Oncology, Pharmaxo, acquisition, strategic parnership

Pharmaxo has announced that it is joining Icon Group as part of a strategic partnership intended to establish a global …
News

Certara to acquire Chemaxon for drug discovery portfolio

July 10, 2024 Business Services Certara, Chemaxon, Pharmacy, acquisition, drug discovery

Certara and Chemaxon have announced that they have signed a definitive agreement under which Certara will acquire Chemaxon. The deal …
News

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024 Business Services Alzheimers, Biogen, Eisai, Leqembi, Neurology, lecanemab

Eisai and Biogen have announced that Leqembi (lecanemab) has been launched in China as a treatment for mild cognitive impairment …
News

Merck to acquire EyeBio for an upfront $1.3bn

May 31, 2024 Business Services EyeBio, Merck, Opthalmology, acquisition, ophthalmology

Merck, known as MSD outside of the US and Canada, and EyeBiotech Limited, have announced that the two companies have …
News

BioGen to acquire Human Immunology Biosciences for $1.15bn

May 23, 2024 Business Services Biogen, HI-Bio, Immunology, acquisition, immunology

BioGen and Human Immunology Biosciences (HI-Bio) have announced that they have entered into a definitive agreement for Biogen to acquire …
News

Merck to acquire Mirus Bio for $600m

May 23, 2024 Business Services Merck, Pharmacy, acquisition, gene therapies

Merck has announced that it has signed a definitive agreement to acquire Mirus Bio for $600m.
News

PharmaTimes Medical & Scientific Excellence Awards and Nursing Industry Excellence Awards are open for entry

May 13, 2024 Business Services MSEA, NIEA, PharmaTimes, awards

Both awards are open for entry until 17 May 2024 and the live awards ceremony will take place on 11 …
News
Press release
The Gateway to Local Adoption Series

Latest content

Pharma sees climate disruption as growing supply-chain risk

September 11, 2026

Manchester NHS-MHRA partnership to test new technologies in real-world care

September 10, 2026

Ondine reports 40% reduction in surgical-site infections in phase 3 trial

September 9, 2026

Northern Ireland to roll out staff well-being training across health service

September 8, 2026

European consortium demonstrates continuous manufacturing platform for pharmaceutical ingredients

September 7, 2026